| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6069586 | Journal of the American Academy of Dermatology | 2016 | 7 Pages |
Abstract
Improved clinical outcome correlated with reduced cathelicidin and protease activity, supporting both the mechanism of doxycycline and the potential of these molecules as biomarkers for rosacea.
Keywords
PTPpapulopustularhCAP18KLKhuman cathelicidinCathelicidin antimicrobial peptideCathelicidinKallikreinMMPBCAGAPDHmRNAcAMPcDNAComplementary DNAmessenger RNAbicinchoninic acid assayInvestigator Global AssessmentIgABiomarkerdoxycyclinerosaceaSerine proteaseadverse eventmatrix metalloproteinasepolyethylene glycolPEGglyceraldehyde-3-phosphate dehydrogenase
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Anna MD, PhD, Anna D. PhD, Yumiko BS, Eugene Y. MD, PhD, Norman PhD, Warren J. MD, PhD, Richard L. MD, PhD,